首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Fibroblast Growth Factor-23 and Incident Atrial Fibrillation The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)
【24h】

Fibroblast Growth Factor-23 and Incident Atrial Fibrillation The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)

机译:成纤维细胞生长因子23与心房颤动的多民族动脉粥样硬化研究(MESA)和心血管健康研究(CHS)

获取原文
获取原文并翻译 | 示例
           

摘要

Background-Fibroblast growth factor-23 (FGF-23) is a hormone that promotes urinary phosphate excretion and regulates vitamin D metabolism. Circulating FGF-23 concentrations increase markedly in chronic kidney disease and are associated with increased risk of clinical cardiovascular events. FGF-23 may promote atrial fibrillation (AF) by inducing left ventricular hypertrophy and diastolic and left atrial dysfunction.
机译:背景-成纤维细胞生长因子23(FGF-23)是一种激素,可促进尿中磷酸盐的排泄并调节维生素D的代谢。在慢性肾脏疾病中,循环中的FGF-23浓度显着增加,并且与临床心血管事件的风险增加有关。 FGF-23可能通过诱导左心室肥大,舒张和左心房功能障碍来促进房颤(AF)。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号